IRIS Accounts Production v26.1.0.640 NI028064 Board of Directors 1.1.25 31.12.25 31.12.25 8/5/26 0 0 false true false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh NI028064 2024-12-31 NI028064 2025-12-31 NI028064 2025-01-01 2025-12-31 NI028064 2023-12-31 NI028064 2024-01-01 2024-12-31 NI028064 2024-12-31 NI028064 ns15:NorthernIreland 2025-01-01 2025-12-31 NI028064 ns14:PoundSterling 2025-01-01 2025-12-31 NI028064 ns10:Director1 2025-01-01 2025-12-31 NI028064 ns10:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 NI028064 ns10:SmallEntities 2025-01-01 2025-12-31 NI028064 ns10:Audited 2025-01-01 2025-12-31 NI028064 ns10:SmallCompaniesRegimeForDirectorsReport 2025-01-01 2025-12-31 NI028064 ns10:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 NI028064 ns10:AbridgedAccounts 2025-01-01 2025-12-31 NI028064 ns10:OrdinaryShareClass1 2025-01-01 2025-12-31 NI028064 ns10:Director2 2025-01-01 2025-12-31 NI028064 ns10:RegisteredOffice 2025-01-01 2025-12-31 NI028064 ns5:CurrentFinancialInstruments 2025-12-31 NI028064 ns5:CurrentFinancialInstruments 2024-12-31 NI028064 ns5:ShareCapital 2025-12-31 NI028064 ns5:ShareCapital 2024-12-31 NI028064 ns5:CapitalRedemptionReserve 2025-12-31 NI028064 ns5:CapitalRedemptionReserve 2024-12-31 NI028064 ns5:RetainedEarningsAccumulatedLosses 2025-12-31 NI028064 ns5:RetainedEarningsAccumulatedLosses 2024-12-31 NI028064 ns5:PlantMachinery 2025-01-01 2025-12-31 NI028064 ns10:OrdinaryShareClass1 2025-12-31 NI028064 ns10:OrdinaryShareClass1 2024-01-01 2024-12-31

REGISTERED NUMBER: NI028064 (Northern Ireland)

| Financial Statements |

| for the Year Ended 31st December 2025 |

| for |

| Analab Analytical Laboratory Supplies |

| Limited |

| Analab Analytical Laboratory Supplies |

| Limited (Registered number: NI028064) |

Contents of the Financial Statements

for the year ended 31st December 2025

Page |

| Company Information | 1 |

| Abridged Balance Sheet | 2 |

| Notes to the Financial Statements | 3 |

| Analab Analytical Laboratory Supplies |

| Limited |

Company Information

for the year ended 31st December 2025

| DIRECTORS: | I. A. Roulstone

| N. A. Bewell

| REGISTERED OFFICE: | Unit 2, 7 Rathdown Close

| Lissue Industrial Estate West

| Lisburn

| Co. Antrim

| BT28 2RB

| REGISTERED NUMBER: | NI028064 (Northern Ireland)

| AUDITORS: | Sadofskys

| Statutory Auditors

| Princes House

| Wright Street

| Hull

| East Yorkshire

| HU2 8HX

| BANKERS: | Danske Bank

| P.O Box 183

| Donegall Square Westt

| Belfast

| BT1 6JS

| Analab Analytical Laboratory Supplies |

| Limited (Registered number: NI028064) |

Abridged Balance Sheet

31st December 2025

| 2025 |  | 2024

| Notes | £ | £ |

CURRENT ASSETS

Debtors | 575 |  | 1,605 |  |

Cash at bank | 8,822 |  | 7,758 |  |

9,397 |  | 9,363 |  |

CREDITORS

Amounts falling due within one year | - |  | 91 |  |

NET CURRENT ASSETS | 9,397 |  | 9,272 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 9,397 |  | 9,272 |  |

CAPITAL AND RESERVES

Called up share capital | 5 | 4,000 |  | 4,000 |  |

Capital redemption reserve | 2,000 |  | 2,000 |  |

Retained earnings | 3,397 |  | 3,272 |  |

SHAREHOLDERS' FUNDS | 9,397 |  | 9,272 |  |

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31st December 2025 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8th May 2026 and were signed on its behalf by:

N. A. Bewell - Director

| Analab Analytical Laboratory Supplies |

| Limited (Registered number: NI028064) |

Notes to the Financial Statements

for the year ended 31st December 2025

1. | STATUTORY INFORMATION

| Analab Analytical Laboratory Supplies Limited is a private company, limited by shares , registered in Northern Ireland. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Related party exemption

| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Plant and machinery etc | - | 25% on reducing balance and 15% on reducing balance

| Analab Analytical Laboratory Supplies |

| Limited (Registered number: NI028064) |

Notes to the Financial Statements - continued

for the year ended 31st December 2025

2. | ACCOUNTING POLICIES - continued

| Financial instruments

| The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial statements.

| Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

| Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

| Basic financial assets, which include debtors, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

| Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

| Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

| Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

| Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

| Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Analab Analytical Laboratory Supplies |

| Limited (Registered number: NI028064) |

Notes to the Financial Statements - continued

for the year ended 31st December 2025

2. | ACCOUNTING POLICIES - continued

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Foreign currencies

| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was NIL (2024 - NIL).

4. | TANGIBLE FIXED ASSETS

| Totals

£ |

| COST

| At 1st January 2025

| and 31st December 2025 | 197,385 |  |

| DEPRECIATION

| At 1st January 2025

| and 31st December 2025 | 197,385 |  |

| NET BOOK VALUE

| At 31st December 2025 | - |  |

| At 31st December 2024 | - |  |

5. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 2025 | 2024 |

| value: | £ | £ |

| 4,000 | Ordinary | £1 | 4,000 |  | 4,000 |  |

| Analab Analytical Laboratory Supplies |

| Limited (Registered number: NI028064) |

Notes to the Financial Statements - continued

for the year ended 31st December 2025

6. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

| The Report of the Auditors was unqualified.

| Alan Brocklehurst (Senior Statutory Auditor)

| for and on behalf of Sadofskys

7. | ULTIMATE PARENT AND CONTROLLING PARTY

| The ultimate controlling party is LBO France, a company registered in France (RCS Strasbourg Reg. No. 418354502). The immediate parent company is SLS Group Limited, a company registered in England and Wales (Reg. No. 03743859).

| The parent of the largest group for which consolidated financial statements are drawn up is Dutscher Holding. Copies of the consolidated accounts can be obtained from 2C, Rue De Bruxelles, 67170, Bernolsheim, France.

| The parent of the smallest group for which consolidated financial statements are drawn up is Scientific Laboratory Supplies Group Limited, whose registered office address is Orchard House, The Square, Hessle, United Kingdom, HU13 0AE.

| Dutscher Holding SAS (incorporated in France) is regarded by the directors as being the company's ultimate parent company (RCS Strasbourg Reg. No. 882634660).